barup-logo.png
MICT, Inc. Reports Third Quarter 2022 Results
14 nov. 2022 09h00 HE | MICT, Inc.
Revenue Increased 15% Quarter-over-Quarter to $13.8 Million Gross Profit from Insurance Business of $3.2 Million Increased 54% Quarter-Over-Quarter and 16% Year-over-Year Gross Margin of...
Logo.png
Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update
14 nov. 2022 08h45 HE | Biofrontera Inc.
Conference call begins at 11:00 a.m. Eastern time today WOBURN, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial Results
14 nov. 2022 08h00 HE | Timber Pharmaceuticals
-Timber Received Orphan Designation from European Commission for Lead Asset TMB-001- -Recruitment for the pivotal Phase 3 ASCEND clinical trial continues to progress; expected to enroll more...
Logo.png
DIGITAL ALLY, INC ANNOUNCES THIRD QUARTER 2022 OPERATING RESULTS
14 nov. 2022 08h00 HE | Digital Ally, Inc.
Third Quarter 2022 Revenues Improve 83% Compared to 2021 LENEXA, Kansas, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY) (the “Company”), today announced its operating...
Logo.png
IMUNON Reports Third Quarter 2022 Financial Results and Provides Business Update
14 nov. 2022 08h00 HE | Imunon, Inc.
Conference Call Today at 11:00 a.m. ET LAWRENCEVILLE, N.J., Nov. 14, 2022 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing...
Logo.png
Cocrystal Pharma Reports Third Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs
14 nov. 2022 08h00 HE | Cocrystal Pharma, Inc.
Completed enrollment in the Phase 1 study with novel, broad-spectrum antiviral PB2 candidate CC-42344 for the treatment of pandemic and seasonal influenza A; remains on track to report topline results...
logo.png
Verano Announces Third Quarter 2022 Financial Results
14 nov. 2022 07h00 HE | Verano Holdings Corp.
CHICAGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its financial results...
Logo.jpg
ProPhase Labs Announces Record Third Quarter 2022 Financial Results
10 nov. 2022 08h00 HE | ProPhase Labs, Inc.
Q3 2022 Net Revenues of $24.2 Million (a Q3 record); Up 155% Year-over-Year Q3 2022 Net Income of $1.0 Million versus a loss in Q3 2021 Q3 2022 adjusted EBITDA of $6.3 million (a Q3...
barup-logo.png
MICT, Inc. to Announce Third Quarter 2022 Financial Results on Monday, November 14, 2022
09 nov. 2022 16h01 HE | MICT, Inc.
MONTVALE, NJ, Nov. 09, 2022 (GLOBE NEWSWIRE) -- MICT, Inc. (NASDAQ: MICT) (“MICT”) announced today it will report its third quarter 2022 financial results pre-market on Monday, November 14, 2022. A...
Logo.jpg
Ballantyne Strong Reports Third Quarter 2022 Operating Results Revenue Increases 68%
08 nov. 2022 16h10 HE | Ballantyne Strong, Inc.
Charlotte, NC, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Ballantyne Strong, Inc. (NYSE American: BTN) (the “Company” or “Ballantyne Strong”) today announced operating results for the third quarter ended...